+91-22-40012000
companysecretary@marksanspharma.com
About
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
R&D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Manufacturing Facilities
Markets
Sample Product Portfolio
Health & Wellness
Consumer Self-Care Products
- OTC
Pain Management
Arthritis
Upper Respiratory
Cough & Cold
Allergy
Digestive Health
VMS
(Vitamins Minerals and Supplements)
Vitamins
Skin Care Products
Hair fall
Prescription
– Rx Therapeutic Segments
Cardiovascular System (CVS)
Central Nervous System (CNS)
Oncology
Anti-Diabetics
Anti-Biotic
R&D
Investor
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Press Release
ESG Profile
Responsibility
CSR
Sustainability
Media
News
Photo / Video Gallery
Adverse Event
Careers
Overview
Values
Life at Marksans
Apply Now
Contact
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Press Release
ESG Profile
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Investor Relations
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Home
Investor Relations
Financial Results
Quarterly Results
Quarterly Results
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2024
June 2024
March 2024
2023
December 2023
September 2023
June 2023
March 2023
2022
December 2022
September 2022
June 2022
March 2022
2021
March 2021
June 2021
September 2021
December, 2021
2020
March 2020
June 2020
September 2020
December 2020
2019
March 2019
June 2019
September 2019
December 2019
2018
March 2018
June 2018
September 2018
December 2018
2017
March 2017
June 2017
September 2017
December 2017
2016
March 2016
June 2016
September 2016
December 2016
2015
March 2015
June 2015
September 2015
December 2015